Alterity Therapeutics Limited reported earnings results for the half year ended December 30, 2023. For the half year, the company reported net loss was AUD 6.51 million compared to AUD 8.03 million a year ago. Basic loss per share from continuing operations was AUD 0.0026 compared to AUD 0.0033 a year ago.

Diluted loss per share from continuing operations was AUD 0.0026 compared to AUD 0.0033 a year ago.